Skip to content

Get Connected Efficacy Trial

Get Connected: Linking YMSM to Adequate Care Through a Multilevel, Tailored WebApp Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03132415
Enrollment
285
Registered
2017-04-27
Start date
2017-11-01
Completion date
2022-06-30
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

Prevention & Control, Internet, Adolescents, Young adults

Brief summary

Get Connected (GC) is an online brief intervention that employs individual and systems-level tailoring technology to reduce barriers to HIV prevention care (e.g., HIV/STI testing, PrEP) for YMSM. The deployment of GC through a mobile-friendly WebApp seeks to optimize online interventions' acceptability, accessibility, availability, long-term affordability among youth. The investigators will enroll self-reported HIV-negative or sero-status unaware, sexually active YMSM (ages 15-24) across three cities and randomize them into the GC intervention condition or to an attention-control condition. Assessments will be collected at 30 days and at 3, 6, 9 and 12 month follow-up.

Detailed description

The number of HIV infections among men who have sex with men aged 15-24 (YMSM) has grown significantly in the past decade. For YMSM to successfully engage in HIV prevention and care services requires that they navigate a series of multilevel barriers operating at the individual (e.g., risk awareness, self-efficacy to get tested), systems (e.g., costs, medical mistrust, lack of culturally competent care), and structural (e.g., homelessness, costs, stigma) levels. The investigators developed Get Connected (GC) as an online brief intervention that employs individual and systems-level tailoring technology to reduce barriers to linkage to competent prevention care (e.g., HIV/STI testing, PrEP) for YMSM (ages 15-24). After a formative phase comprised of assessing HIV testing sites' performance via a mystery shopping procedure, the investigators will test the efficacy of GC for increasing YMSM's successful engagement in locally appropriate HIV prevention and care using a two-arm randomized controlled trial. The trial will compare the full GC intervention to the GC HIV test locator. Participants will be recruited from three cities (Houston, Philadelphia and Atlanta) characterized by high HIV incidence, and followed over 12 months. Assessments will be collected at 30 days and at 3, 6, 9 and 12 month follow-up. Specific Aims include: Aim 1: Examine the quality of HIV test counseling and PrEP-related referrals to YMSM within local HIV/STI testing sites in 3 cities (Houston, Philadelphia & Atlanta). Aim 2: Test the efficacy of GC for increasing HIV-negative or HIV-unknown YMSM's successful uptake of HIV prevention services (e.g., routine HIV/STI testing) and PrEP awareness and willingness, as compared to the attention-control condition over a 12-month period. Aim 3: Qualitatively assess sites' satisfaction with performance assessments and their improvements in service delivery when working with YMSM across the three regions.

Interventions

BEHAVIORALGet Connected

The investigators designed the intervention to help participants increase their HIV risk awareness, promote self-appraisal and increase motivation for engaging in prevention services, problem solving barriers to accessing care, and locating culturally-sensitive providers. Intervention content is customized based on participants' socio-demographic characteristics, HIV/STI testing history and testing motivations, and recent sexual behaviors.

BEHAVIORALHIV Test Locator

The investigators will use a HIV/STI testing locator as the attention-control condition. The test locator provides a list of HIV testing sites in a city or zipcode.

Sponsors

University of North Carolina
CollaboratorOTHER
University of Michigan
CollaboratorOTHER
University of Minnesota
CollaboratorOTHER
Emory University
CollaboratorOTHER
Children's Hospital of Philadelphia
CollaboratorOTHER
Baylor College of Medicine
CollaboratorOTHER
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
15 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

* Assigned male sex at birth and currently identifies as male * Aged 15 to 24 years (inclusive) at time of screening * Self-report as HIV-negative or sero-status unaware * Speak and read English * Not be on PrEP at time of enrollment * Report having consensual anal sex with a male partner in the prior 6 months * Reside in Philadelphia, Houston, or Atlanta * Access to internet

Exclusion criteria

* Assigned female sex at birth * Assigned male sex at birth but identifies as transgender or gender non-conforming * Aged 14 years or younger or 25 years or older at time of screening * HIV-positive * Does not speak or read English * Currently taking PrEP * Did not have consensual anal sex with a male partner in the prior 6 months * Does not reside in Philadelphia, Houston, or Atlanta * Currently incarcerated * Planning to move out of the region in next 12 months

Design outcomes

Primary

MeasureTime frameDescription
Percent of Participants Reporting Changes in Their HIV Testing Behavior Using Self-report Questionnaires12 monthThe investigators will estimate the proportion of participants who test at least twice for HIV over a 12-month period by intervention group.

Secondary

MeasureTime frameDescription
Percent of Participants Reporting Changes in PrEP Uptake Using Self-report Questionnaires12 monthThe investigators will test the proportion of the sample that begins PrEP during the 12-month follow-ups.
Percent of Participants Reporting Changes in Their STI Testing Behavior Using Self-report Questionnaires12 monthThe investigators will estimate the proportion of participants who test for STIs at least once over the trial period.

Countries

United States

Participant flow

Participants by arm

ArmCount
Get Connected
Get Connected is a brief intervention focused on resolving ambivalence about HIV prevention behaviors, increasing self-efficacy for change, and enhancing motivation moving toward action. Get Connected: The investigators designed the intervention to help participants increase their HIV risk awareness, promote self-appraisal and increase motivation for engaging in prevention services, problem solving barriers to accessing care, and locating culturally-sensitive providers. Intervention content is customized based on participants' socio-demographic characteristics, HIV/STI testing history and testing motivations, and recent sexual behaviors.
143
HIV Test Locator
Participants randomized to the control condition will receive the Get Connected testing site locator. Given the availability of search engines to locate HIV/STI testing sites, the test locator condition may be considered usual care. HIV Test Locator: The investigators will use a HIV/STI testing locator as the attention-control condition. The test locator provides a list of HIV testing sites in a city or zipcode.
142
Total285

Baseline characteristics

CharacteristicHIV Test LocatorTotalGet Connected
Age, Continuous21.11 years
STANDARD_DEVIATION 2.189
21.14 years
STANDARD_DEVIATION 2.086
21.17 years
STANDARD_DEVIATION 1.986
Ethnicity (NIH/OMB)
Hispanic or Latino
27 Participants57 Participants30 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
115 Participants228 Participants113 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants6 Participants3 Participants
Race (NIH/OMB)
Asian
14 Participants33 Participants19 Participants
Race (NIH/OMB)
Black or African American
31 Participants52 Participants21 Participants
Race (NIH/OMB)
More than one race
19 Participants29 Participants10 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants2 Participants1 Participants
Race (NIH/OMB)
White
74 Participants163 Participants89 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
142 Participants285 Participants143 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1430 / 142
other
Total, other adverse events
0 / 1430 / 142
serious
Total, serious adverse events
0 / 1430 / 142

Outcome results

Primary

Percent of Participants Reporting Changes in Their HIV Testing Behavior Using Self-report Questionnaires

The investigators will estimate the proportion of participants who test at least twice for HIV over a 12-month period by intervention group.

Time frame: 12 month

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Get ConnectedPercent of Participants Reporting Changes in Their HIV Testing Behavior Using Self-report Questionnaires53 Participants
HIV Test LocatorPercent of Participants Reporting Changes in Their HIV Testing Behavior Using Self-report Questionnaires54 Participants
Secondary

Percent of Participants Reporting Changes in PrEP Uptake Using Self-report Questionnaires

The investigators will test the proportion of the sample that begins PrEP during the 12-month follow-ups.

Time frame: 12 month

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Get ConnectedPercent of Participants Reporting Changes in PrEP Uptake Using Self-report Questionnaires38 Participants
HIV Test LocatorPercent of Participants Reporting Changes in PrEP Uptake Using Self-report Questionnaires36 Participants
Secondary

Percent of Participants Reporting Changes in Their STI Testing Behavior Using Self-report Questionnaires

The investigators will estimate the proportion of participants who test for STIs at least once over the trial period.

Time frame: 12 month

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Get ConnectedPercent of Participants Reporting Changes in Their STI Testing Behavior Using Self-report Questionnaires73 Participants
HIV Test LocatorPercent of Participants Reporting Changes in Their STI Testing Behavior Using Self-report Questionnaires75 Participants

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026